Arena Pharmaceuticals Inc (ARNA)

NASDAQ
65.30
+0.77(+1.19%)
  • Volume:
    197,450
  • Bid/Ask:
    63.00/66.70
  • Day's Range:
    63.78 - 65.79

ARNA Overview

Prev. Close
64.53
Day's Range
63.78-65.79
Revenue
60K
Open
64.58
52 wk Range
59.55-90.19
EPS
-7.37
Volume
197,450
Market Cap
3.96B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
562,486
P/E Ratio
-
Beta
0.54
1-Year Change
4.7%
Shares Outstanding
60,696,200
Next Earnings Date
Nov 10, 2021
What is your sentiment on Arena Pharmaceuticals Inc?
or
Market is currently closed. Voting is open during market hours.

Arena Pharmaceuticals Inc News

Arena Pharmaceuticals Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralNeutralBuySellBuy
Technical IndicatorsStrong SellNeutralStrong BuyStrong SellBuy
SummarySellNeutralStrong BuyStrong SellBuy

Arena Pharmaceuticals Inc Company Profile

Arena Pharmaceuticals Inc Company Profile

Employees
363

Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide. Its investigational clinical programs include Etrasimod (APD334) that is in Phase III clinical trial for ulcerative colitis, Phase IIb/III clinical trial for Crohn’s disease, Phase II clinical trial for alopecia areata, Phase III clinical trial for atopic dermatitis, and Phase IIb clinical trial for eosinophilic esophagitis; Olorinab (APD371), which is in Phase IIb clinical trial for the treatment of abdominal pain associated with irritable bowel syndrome; APD418 that is in Phase I clinical trial for acute heart failure; and Temanogrel for coronary microvascular obstruction is in Phase II clinical trial. It also develops ralinepag (APD811), which is in Phase III clinical trial for pulmonary arterial hypertension. The company has collaboration agreements with United Therapeutics Corporation; Everest Medicines Limited; Beacon Discovery; Boehringer Ingelheim International GmbH; and Eisai Co., Ltd. and Eisai Inc. Arena Pharmaceuticals, Inc. was incorporated in 1997 and is based in Park City, Utah.

Read More
  • long hold
    0
    • Better wear a cup and a helmet at breakfast.
      1
      • 2021 will be a huuugggeee year for ARNA.
        0
        • good to hear but why thx
          0
        • Why is that?
          0
      • Good breakout from pennant
        0
        • Long term BUY. Several positive catalysts occurring in 2017.
          1
          • Option BUY.
            1
            • Hope you right .
              1
            • How many shares,per purchases
              1
          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.